University of Queensland researchers are leading the charge in adapting drug dosing to a society that is changing shape.

We encounter valves every day, whether in the water faucet, the carburetor in our car, or our bicycle tire tube. Valves are also present in the world of nanotechnology. A team of researchers headed by J. Fraser Stoddart and Jeffrey I. Zink at the University of California, Los Angeles, has now developed a new nanovalve.

A Glasgow-based drug research institute, specialising in psychiatric drug development, is expanding its work to offer comprehensive services to companies and scientific partners.

Another recall for GlaxoSmithKline. It seems to become a habit.

Bayer AG fell to the lowest level in a year in Frankfurt trading after a U.S. judge invalidated a patent on the Yasmin contraceptive, giving Barr Pharmaceuticals Inc. a chance to sell a cheaper copy.

When national drug use trends among adolescents go up or down, the risk of marijuana use among deviance-prone male youth also goes up or down. Among deviance-prone female youth, it does not, according to a study in the March issue of Prevention Science.

One of the cornerstones of the Swedish drugstore monopoly can now be sold in ordinary stores. Nicotine replacements, such as chewing gum, can now be sold in stores and supermarkets in Sweden as of Saturday.

In an article featured on the cover of the March issue of “Nature Nanotechnology,” Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective.

A new study finds that the use of stimulant drugs to treat children with ADHD has no effect on their future risk of substance abuse.

A drug related to the class of proton pump inhibitors, most effective in reducing gastric acid secretion, was approved for the use in children.

Differences in gene expression levels between people of European versus African ancestry can affect how each group responds to certain drugs or fights off specific infections, report researchers from the University of Chicago Medical Center and the Expression Research Laboratory at Affymetrix Inc. of Santa Clara, CA.

A new compound that blocks an early step in cell death could lead to a novel class of drugs for treating heart attacks and stroke.